Equities

Autobio Diagnostics Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Autobio Diagnostics Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)36.47
  • Today's Change-0.150 / -0.41%
  • Shares traded1.73m
  • 1 Year change-10.39%
  • Beta0.8530
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Autobio Diagnostics Co Ltd is a China-based company primarily engaged in the research and development, manufacturing, integration and service of in vitro diagnostic reagents and instruments. The Company's main products include immunoassay reagents, microbiological detection reagents, molecular diagnostic detection reagents, biochemical detection reagents, immunoassay instruments, microbiological detection instruments, molecular detection instruments, mass spectrometry detection instruments, auxiliary testing instruments and other products. The Company conducts its business in the domestic and overseas markets.

  • Revenue in CNY (TTM)4.22bn
  • Net income in CNY1.10bn
  • Incorporated1999
  • Employees5.77k
  • Location
    Autobio Diagnostics Co LtdNo.87 Jingbei Yi Rd.National Eco, Zhengzhou, Henan 450016ZHENGZHOU 450016ChinaCHN
  • Phone+86 37 186506868
  • Fax+86 37 186506767
  • Websitehttps://www.autobio.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beijing Hotgen Biotech Co Ltd434.45m-259.33m13.37bn903.00--4.56--30.77-3.04-3.044.9831.630.13131.964.23481,114.30-7.9721.79-8.4724.9356.3855.43-60.7129.144.77--0.016844.35-6.7419.41-760.40---10.29--
Beijing Balance Medical Technolgy Co Ltd591.28m180.33m14.21bn611.0078.7311.41--24.041.311.314.299.040.42681.275.08967,721.8011.938.0312.978.4486.7888.9327.9527.672.89--0.066876.3235.4128.0127.0218.33140.7741.14
Micro-Tech Nanjing Co Ltd3.12bn611.40m15.47bn2.46k25.253.80--4.953.263.2616.6521.680.64011.936.361,267,666.0013.0010.5615.9312.6164.0963.4620.3019.113.30--0.062633.6514.2616.0813.8512.7538.21--
Shandong Weigao Bld Prfctn Prdcts Co Ltd3.70bn474.39m16.92bn3.48k36.612.42--4.581.111.118.5216.71------1,060,956.00--------39.57--12.84--2.62--0.0007--2.03--1.65------
Autobio Diagnostics Co Ltd4.22bn1.10bn20.93bn5.77k19.062.39--4.961.921.927.3715.310.3651.583.55730,698.709.5411.2712.0714.1963.2861.7526.1426.612.13--0.007848.990.619910.78-1.899.06-2.71--
Zhende Medical Co Ltd4.32bn280.90m23.60bn7.81k84.204.15--5.461.051.0516.2221.400.53113.706.19553,702.603.5715.124.5620.1632.1937.756.7216.681.23--0.190630.863.3217.9594.1419.6822.9616.18
iRay Group2.02bn545.59m26.20bn1.66k45.874.31--12.942.702.7010.0328.740.20731.252.74--5.419.746.0311.1747.8654.6826.1133.283.25--0.385132.63-1.7427.38-23.4337.00104.75--
MGI Tech Co Ltd3.01bn-257.01m28.18bn2.60k--3.65--9.35-0.6175-0.61757.2318.550.30021.282.371,156,828.00-2.623.69-3.035.1349.7758.81-8.749.123.67--0.116719.123.4822.521.10--12.79--
Data as of Feb 11 2026. Currency figures normalised to Autobio Diagnostics Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

6.42%Per cent of shares held by top holders
HolderShares% Held
Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 202514.44m2.46%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 20258.76m1.50%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 20255.77m0.99%
China Southern Asset Management Co., Ltd.as of 30 Jun 20252.55m0.44%
The Vanguard Group, Inc.as of 31 Dec 20251.44m0.25%
China Universal Asset Management Co., Ltd.as of 30 Jun 20251.43m0.24%
Guotai Asset Management Co., Ltd.as of 30 Jun 20251.29m0.22%
GF Fund Management Co., Ltd.as of 30 Jun 2025798.85k0.14%
E Fund Management Co., Ltd.as of 30 Jun 2025699.69k0.12%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025463.70k0.08%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.